Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

Treatment options for patients with metastatic synovial sarcoma are limited. Over recent years, trabectedin has emerged as an effective agent for patients with advanced soft tissue sarcomas resistant to anthracyclines and ifosfamide. The aim of this retrospective analysis was to study the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanfilippo, Roberta, Dileo, Palma, Blay, Jean-Yves, Constantinidou, Anastasia, Le Cesne, Axel, Benson, Charlotte, Vizzini, Laura, Contu, Marianna, Baldi, Giacomo G., Dei Tos, Angelo P., Casali, Paolo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730787/
https://www.ncbi.nlm.nih.gov/pubmed/25763543
http://dx.doi.org/10.1097/CAD.0000000000000228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730787/
https://www.ncbi.nlm.nih.gov/pubmed/25763543
http://dx.doi.org/10.1097/CAD.0000000000000228

Ejemplares similares